IREN's spending and ongoing financing still weigh on its shares despite a signed Anthropic deal. Its 2027 capex is put at $25-30B and its $6B ATM appears roughly halfway complete. Mirantis has improved fundamentals, but markets likely care more in about six months as revenue approaches and the ATM/capex window passes, as with Nebius after its Meta deal. A risk-off rotation to larger names adds pressure. x.comÂ